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Abstract
Background: The Patient Activation Measure (PAM) is a measure that assesses patient
knowledge, skill, and confidence for self-management. This study validates the Danish translation
of the 13-item Patient Activation Measure (PAM13) in a Danish population with dysglycaemia.
Methods: 358 people with screen-detected dysglycaemia participating in a primary care health
education study responded to PAM13. The PAM13 was translated into Danish by a standardised
forward-backward translation. Data quality was assessed by mean, median, item response, missing
values, floor and ceiling effects, internal consistency (Cronbach's alpha and average inter-item
correlation) and item-rest correlations. Scale properties were assessed by Rasch Rating Scale
models.
Results: The item response was high with a small number of missing values (0.8–4.2%). Floor effect
was small (range 0.6–3.6%), but the ceiling effect was above 15% for all items (range 18.6–62.7%).
The -coefficient was 0.89 and the average inter-item correlation 0.38. The Danish version formed
a unidimensional, probabilistic Guttman-like scale explaining 43.2% of the variance. We did
however, find a different item sequence compared to the original scale.
Conclusion: A Danish version of PAM13 with acceptable validity and reliability is now available.
Further development should focus on single items, response categories in relation to ceiling effects
and further validation of reproducibility and responsiveness.
Background
Several initiatives have been taken to develop evidence-
based activities to improve care for chronic conditions
and, as in the Chronic Care Model, collaborative care and
patient activation are cornerstones [1,2]. Evaluations of
these initiatives are essential for further research and
development. Although patient activation has been a cen-
tral concept of chronic care for decades, there is a general
lack of clarity regarding the definition of "activation", and
consequently a lack of adequate assessment tools.
In 2004, Hibbard et al defined the concept of being "acti-
vated" and developed the Patient Activation Measure
(PAM) 22 item and a 13 item short form (PAM13) [3,4].
They identified four elements; knowledge, skills, confi-
dence and behaviours critical for coping with a chronic ill-
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go through on their way to becoming fully activated in
managing their own health [4,5]. Studies indicate that the
PAM-measure predicts self-management behaviours,
including healthy behaviours, disease-specific behaviours
and "attitude to health system" – behaviour [6,7]. The
PAM was formulated in two versions targeted people with
or without chronic disease, with few semantic differences.
Psychometric, PAM was evaluated to be a unidimen-
sional, Guttman-like scale [3]. The PAM13 version for the
chronically ill was used in this validation study (Table 1).
The aims of this study were to translate and adapt the orig-
inal American PAM13 into a Danish version and to report
data quality and psychometric scale properties in a Dan-
ish population with dysglycaemia.
Methods
Translation and adaptation of the PAM13
A systematic approach to translation and adaptation was
conducted as recommended by WHO [8]. It implies five
steps: forward-translation, expert panel discussion, back-
ward translation, a pre-test, a cognitive briefing and a con-
sensus on the final version. Two independent native
translators with Danish as their mother-tongue translated
the original version of PAM13 from American English to
Danish. These two translators comprised the expert panel
together with three experts in chronic care and measure-
ment development. The panel reconciled the forward
translation into a single translation by identifying and
resolving inadequate expressions or concepts. Back-trans-
lation was done as a quality control step to ensure that the
original meaning of the concepts was derived. The back-
translations were conducted by two independent native
translators with American/English as their mother tongue
and without knowledge of the questionnaire beforehand.
A pretest investigated the level of comprehensibility and
cognitive equivalence of the translation [9,10] among 12
patients with newly diagnosed type 2 diabetes from a local
diabetes outpatient clinic. The patients filled in the ques-
tionnaire at home and participated in a focus group inter-
view on the following day. The interviewer (first author)
facilitated a cognitive briefing on general comprehensive-
ness followed by a review of each question. The partici-
pants were asked to think out loud, highlight problems
and express their attitude to the question. The final ver-
sion of the questionnaire was resolved by the expert panel,
and a simple and acceptable language was ensured in
accordance with the WHO guidelines [8].
Participants
The Danish version of PAM13 was sent to 467 participants
in "The Ready to Act" health education randomised con-
trolled study (296 in the intervention and 171 in the con-
trol group) at the 12-month follow-up [11]. Participants
were between 43 and 75 years and diagnosed with differ-
ent aspects of dysglycaemia (Impaired Fasting Glucose,
Impaired Glucose Tolerance and Type 2 diabetes) by a
step-wise screening procedure in general practice within
the last five years [12,13]. Participants received a mail-
administered PAM13 as part of a larger 16-page 1-year fol-
low questionnaire on the psychological and behavioural
outcomes of the "Ready to Act" study. A reminder includ-
ing a new questionnaire was sent to participants who did
not respond within three weeks.
Ethics
Ethical approval of the study was attained from the local
Science Ethics Committee of Aarhus County, Denmark
(protocol no: 20000183). All participants gave informed
content. The Danish Data Surveillance Authority permit-
ted the collection and storing of data (journal no: 2000-
41-0042).
Scoring
Each item had five response categories with scores from 1
to 5: (1) strongly disagree, (2) disagree, (3) agree, (4)
Table 1: Thirteen-Item Patient Activation Measure
item
1 When all is said and done, I am the person who is responsible for managing my health condition
2 Taking an active role in my own health care is the most important factor in determining my health and ability to function
3 I am confident that I can take actions that will help prevent or minimize some symptoms or problems associated with my health condition
4 I know what each of my prescribed medications do
5 I am confident that I can tell when I need to go get medical care and when I can handle a health problem myself
6 I am confident I can tell my health care provider concerns I have even when he or she does not ask
7 I am confident that I can follow through on medical treatments I need to do at home
8 I understand the nature and causes of my health condition(s)
9 I know the different medical treatment options available for my health condition
10 I have been able to maintain the lifestyle changes for my health that I have made
11 I know how to prevent further problems with my health condition
12 I am confident I can figure out solutions when new situations or problems arise with my health condition
13 I am confident that I can maintain lifestyle changes like diet and exercise even during times of stressPage 2 of 9
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sum-scale. Only PAM-questionnaires with answers to
seven or more items were included in the analyses. If
included questionnaires had missing observations, these
observations were omitted from the analysis, but not the
corresponding persons or items. The raw scores were
transformed into natural logarithms to achieve a better
expression of the relative distances between the scores
[14]. Further, items were calibrated from the logit metric
to a user-friendly 0 to100 metric (0 = lowest activation
level, 100 = highest activation) [15] to compare the Dan-
ish results to the original data.
Analyses and statistical methods
The psychometric elements of the PAM13 Danish version
were examined in two parts.
First, we assessed the data quality, internal consistency
and correlations between items and the sum of the other
items. Data quality was assessed in terms of mean for each
item with standard deviation, median, percentage of miss-
ing data, number of "not applicable" answers and extent
of ceiling and floor effects. Floor and ceiling effects
between 1–15% were defined as optimal [16]. Internal
consistency was assessed using Cronbach's alpha and
average inter-item correlation. We defined an alpha of
0.80 as the lowest acceptable value [17-19]. In contrast to
alpha, the average inter-item correlation is independent of
the number of items and sample size when measuring
internal consistency. We aimed at an average inter-item
correlation between 0.15–0.50 [19].
We assessed whether each item had a high correlation
with the sum score of the rest of the scale (internal item
convergence), which is assumed in a unidimensional
scale [17]. Correlations were fixed at a minimum of 0.60
to reflect a high level of internal convergence [20].
Secondly, we used Rasch Rating Scale Model [21,22] to
investigate whether the scale was unidimensional, which
is a prerequisite for the summation of the items [23]. The
following criteria for Rasch model were investigated; item
statistics, person and item reliability, rating scale diagnos-
tics, factorial test of residuals and differential item func-
tioning.
In the Rasch analysis, person and item scores were used to
calibrate items on a logit scale where the midpoint of the
scale is 0. Items at one end of the scale are "easier"/"less
severe" and items at the other end are more "difficult"/
"more severe". In the current analysis, items with a posi-
tive calibration were those indicating a high level of
patient activation (more difficult to achieve).
From the Rasch model, we reported reliability and separa-
tion index for persons and items, and item statistics for
measure order. Reliability expresses the reproducibility of
the relative measure. A high reliability indicates that in all
probability, persons (or items) with high measures actu-
ally do have higher measures than persons (or items) esti-
mated with low measures. Winsteps [24] computes upper
(Model) and lower (Real) boundary values for reliability.
The true reliability can be found between these bounda-
ries. Person reliability of 0.9 means that the scale may dis-
criminate the sample into 3–4 levels, 0.8 into 2–3 levels
and 0.5 into 1–2 levels. High item reliability merely indi-
cates that the sample is big enough to precisely locate the
items on the latent variable. We compared Rasch person
reliability for subgroups to the original data [4].
An important characteristic of a high-quality scale is a
good overall separation of persons and items assessed
with the scale. The separation index is an estimate of the
spread or separation of persons (or items) on the meas-
ured dimension. The separation index should be at least
2, indicating that the measure separated persons, items or
both into at least two distinct groups [14]. Individual
items that are at least 0.15 logits apart represent individual
strata [25]. Otherwise one item is not distinctly separate
from the next.
Two item fit mean square (MNSQ) statistics (infit and
outfit) were computed to check whether the items fitted
the expected model. MNSQ determines how well each
item contributes to defining a single underlying construct
(unidimensionality). Infit is more sensitive to misfitting
responses to items closest to the person's ability level,
while outfit is more sensitive to misfitting items that are
farther away. If the data fit the Rasch model, the fit statis-
tics should be between 0.6 and 1.4 [26].
The assumption is that the use of response categories for
each item reflects the way people answer the items that are
close to each other. However, this is only true if the dis-
tances between each response category are similar. The
step measure (Rasch-Andrich threshold) is a calibrated
measure of the transition between response categories.
The thresholds are expected to increase monotonically. If
not, the response categories do not reflect a reasonable
interval on the latent variable, and consequently indicate
substantial problems with the category definitions.
Thresholds should increase by at least 1.4 logits, to show
distinction between categories, but not more than 5.0 log-
its, to avoid large gaps in the variable [14].
Local independence of items was tested using Principal
Components Analysis (PCA) on the Rasch item measure
residuals. The purpose of PCA of residuals is to analyse the
amount of unexplained variance and whether this unex-Page 3 of 9
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one dimension. Simulation studies indicate that even
Rasch-conforming data produces residual-factors with
eigenvalues up to 2.0. Thus, if there is more than one con-
trast (factors) in the residuals, there may be a second
dimension. Contrasts in the Rasch analysis of residuals
contradict unidimensionality [24].
As the last part of the Rasch analysis, we assessed differen-
tial item functioning (DIF) by estimating item parameters
separately by groups of participants (sex, age groups, diag-
nosis, education, self-rated health and randomisation
group). The scale should work uniformly, irrespective of
the group assessed. The criteria used for the DIF analysis
was DIF contrast >0.50. We tested using t-test and com-
pared the probability multiplied by the number of DIF
tests for each variable with a significance level of 0.05 to
correct for multiple comparisons by the Bonferroni
method.
Analyses were performed with Stata 10 [27] and Winsteps
Rasch models software application [24].
Results
Translation and adaptation
The two translations from American to Danish agreed on
most items. Different Danish words were used, but were
semantically equivalent. A few conceptual discrepancies
were identified; for example "health care", "medical care"
and "treatment" had slightly different meanings, when
used directly translated into Danish (item 5, 7, 9). The
two translated versions were reconciled into a single trans-
lation relevant for Danish terminology at expert panel
meetings between the translators and the research group.
The first back-translation included all items; the second
back-translation included four items (item 2, 4, 7, 13).
The emphasis in the back translation was on the concep-
tual and cultural equivalence, and not the linguistic as
suggested by WHO [8]. We recognised a few general prob-
lems when comparing the two back-translations with the
original version [4] and the first Danish draft: As in the
forward-translation, we had difficulty translating health
service terminology, partly because of organisational dif-
ferences, and partly because a lack of specific Danish
words for health care, illness and disease.
In the pre-test, the participants found all thirteen items
relevant for measuring activation. The participants found
the introductory wordings easy to understand; in addition
they considered the response-categories exhaustive and
exclusive. The participants found that the word "treat-
ment" directed their attention to medication rather than
diet or exercise. As half of the participants did not receive
medication, they suggested that this elaborated term;
"treatment (e.g. medicine, diet and exercise)" was used in
the introductory wordings and in item two and seven. The
expert group incorporated the results from the briefing
process in the draft version, and proofreaders corrected
the spelling and grammar.
Participants
A total of 358 of 467 (76.7%) returned the questionnaire.
Excluding "not applicable" answers, 344 had answered at
least 50% of the items (>6 items) in PAM13. The mean
age of the participants was 62.3 (s.d.: 7.1), 44.8% were
female, 60.5% had type 2 diabetes and 39.5% had a pre-
diabetic condition. The respondents had been diagnosed
within the last five years (median 2 year (interquartiles 0–
4).
Data quality
The item response was high with few missing answers
(0.8–4.2%) (Table 2). The response category "not applica-
ble" was used by 0.6–18.4% of responders. In five of the
items (4, 9, 11, 12 and 13) this category represented more
than 10% of the answers. For all items, the distribution of
answers was left-skewed with a small floor effect (range
0.6–3.6%) and a ceiling effect larger than 15% (range
18.6–62.7%) for all items. Cronbach's alpha was 0.89 and
average inter-item correlation 0.38. Item-rest correlations
(Table 2) ranged from 0.48–0.65 and were below 0.60 for
six items (1, 4, 5, 6, 11 and 13).
Rasch analysis
Item statistics
The item infit and outfit mean square statistics ranged
from 0.67–1.34, which all are within the acceptable range
(Table 3). Separation distances of at least 0.15 logits were
identified for nine of the 12 separations between items,
but not for separations between items 2 and 3, items 10
and 9 and items 9 and 5 (Table 3). The calibrated 0–100
scale covered the range from 33.3–57.5.
Person and item reliability
The overall Rasch person reliability for the Danish 13-
item measure was between 0.83 (real) and 0.85 (model).
Item reliability was 0.99. The separation index for persons
was 2.24 and for items 8.37. Table 4 shows the person reli-
ability statistics for subgroups in Danish populations
compared with the American data. The person reliability
was between 0.54 (real) and 0.92 (model). Some sub-
groups had a reliability below 0.80 (excellent self-rated
health and age group 75 years or above).
Rating scale diagnostics
The summary of measured steps is displayed in Table 5.
This table shows the category label, observed counts, aver-
age measures, infit and outfit MNSQ, and step measures
on the PAM13 scale. The category "Strongly disagree" wasPage 4 of 9
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58% of all answers. However, both the average measure
and the thresholds increased monotonically across the
rating scale. The increase of the thresholds ranged from
1.4–4.2, which was within the targeted range.
Factorial test of residuals
PCA of item measure residuals revealed one dimension. A
total of 43.2% of the variance in the data was explained by
the measures and with a perfect model fit, this was
expected to be 43.1%. The eigenvalue of the first PCA con-
trast was 2.5, which corresponded to 11% of the variance
in the data.
Differential item functioning
No significant DIF was found in subgroups of self-rated
health, diagnosis or randomisation groups. Items 1 and 2
were easier to endorse for highly educated persons com-
pared to persons with short education (p-values Bonfer-
roni-corrected) (DIF contrast = 1.35, p = 0.027 and DIF
contrast = 1.22, p = 0.031). Item 10 was easier to endorse
for men (DIF contrast = -0.65, p = 0.049) and item 13 was
easier to endorse for persons between 65 and 74 years
Table 2: Data quality and item-rest correlations of the 13-items Patient Activation Measure Danish version in a population with 
dysglycaemia (n = 358). 
Item N Mean SD Median Missing values "Not applicable" Floor Ceiling Item-rest correlation
358 % of N = 358 % of N = 358 % %
1 351 3.61 0.53 4 0.8 1.1 0.6 62.7 0.53
2 352 3.50 0.56 4 1.1 0.6 0.6 52.6 0.60
3 348 3.51 0.59 4 1.7 1.1 1.2 54.6 0.61
4 277 3.19 0.67 3 4.2 18.4 2.5 31.4 0.53
5 316 3.04 0.73 3 2.0 9.8 2.9 26.3 0.52
6 334 3.29 0.65 3 1.7 5.0 1.5 38.3 0.48
7 340 3.39 0.55 3 2.0 3.1 0.6 42.1 0.62
8 321 3.31 0.60 3 1.7 8.7 0.9 37.4 0.61
9 287 3.07 0.69 3 2.0 17.9 2.1 25.4 0.64
10 327 3.05 0.69 3 2.0 6.7 1.8 24.5 0.60
11 313 3.13 0.59 3 2.2 10.3 1.0 23.6 0.57
12 290 3.00 0.63 3 1.7 17.3 1.0 18.6 0.65
13 308 2.89 0.77 3 1.1 12.9 3.6 21.1 0.59
For the overall scale Cronbach's alpha was 0.89, average inter-item correlation 0.38
Table 3: Thirteen-items Patient Activation Measure with Item Calibrations ordered by difficulty calibration
Item N = 344 Measure (logits) SEM Measure (0–100 scale) SEM Infit MNSQ Outfit MnSQ
1 342 -1.95 0.13 33.3 0.9 0.97 0.93
3 339 -1.38 0.12 37.3 0.9 0.98 0.94
2 342 -1.32 0.12 37.7 0.9 0.94 0.91
7 334 -0.76 0.12 41.7 0.9 0.82 0.81
8 319 -0.35 0.12 44.7 0.9 0.92 0.88
6 328 -0.21 0.12 45.7 0.9 1.34 1.30
4 277 0.30 0.13 49.3 0.9 1.23 1.20
11 313 0.53 0.12 50.9 0.8 0.86 0.87
10 324 0.85 0.11 53.2 0.8 0.99 1.01
9 287 0.86 0.12 53.3 0.8 0.91 0.94
5 314 0.86 0.11 53.3 0.8 1.28 1.29
12 289 1.11 0.11 55.1 0.8 0.67 0.69
13 305 1.45 0.11 57.5 0.8 1.05 1.16
Measure (logits): The estimate for the item difficulty in logits.
Measure (0–100 scale): The rescaled estimate for the item difficulty.
SEM: The standard error of measurement in estimation of the item difficulty. SEM is the precision of the item difficulty estimation and is shown in 
logits and 0–100 units.
Infit MNSQ: Infit mean square error is one of two quality control fit statistics assessing item dimensionality (the degree to which the item falls on 
the same single, real number line as the rest of the items). Infit is an information-weighted residual of observed responses from model expected 
responses and is most sensitive to item fit when the item is located near the person's scale location.
Outfit MNSQ: Outfit mean square error fit statistic is most sensitive to item dimensionality when the item scale location is distant from the 
person's scale location [4].Page 5 of 9
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p<0.001) and compared to persons between 55 and 64
years (DIF contrast = 0.9, p = 0.023).
Discussion
We found it possible to make a standardised translation
and adaption of the original PAM13. The forward-back-
ward translation was successfully conducted and the few
discovered conceptual differences were primarily due to
differences in health care systems. These findings are sup-
ported by the fact that e.g. the reliabilities in subgroups
were comparable with the American version.
The psychometric assessment of the Danish version repli-
cated to a great extent the findings from the original ver-
sion [4] showing similar data quality and internal
consistency. We found that the items had a different
order. The items are arranged progressively in order of dif-
ficulty to reflect the developmental continuum of patient
activation in an American population with chronic dis-
eases. However, this was not confirmed by the results in
this study, meaning that this population simply found
some questions easier to answer compared with an Amer-
ican population. This could be due to the specific popula-
tion of people with screen-detected newly diagnosed
Table 4: Reliability of 13-item Patient Activation Measure of the Danish version compared with the American version [4]
Rasch Person Reliability
PAM 13 PAM 13 Danish American
N % Danish American Real Model Real Model
Sample 344 100 64.2 61.9 0.83 0.85 0.81 0.85
Gender
Male 190 55.2 63.8 60.2 0.82 0.85 0.80 0.84
Female 154 44.8 64.7 62.8 0.85 0.86 0.82 0.85
Age group
-54 52 15.1 62.5 63.9* 0.82 0.86 0.88* 0.91*
55–64 149 43.3 63.9 61.7 0.85 0.86 0.88 0.91
65–74 137 39.8 65.6 61.9 0.82 0.84 0.89 0.91
75+ 6 1.7 56.6 58.2* 0.54 0.56 0.87* 0.90*
Self-rated health
Poor 6 1.8 57.4 54.3 0.91 0.92 0.73 0.78
Fair 44 13.1 62.5 57.3 0.81 0.85 0.78 0.83
Good 189 56.4 62.6 59.3 0.82 0.85 0.78 0.82
Very good 83 24.8 66.6 64.3 0.84 0.86 0.79 0.83
Excellent 13 3.9 76.3 68.7 0.77 0.78 0.83 0.85
Education
Unskilled 98 32.3 65.0 58.5^ 0.82 0.84 0.75^ 0.80^
Short (1–3 years) 130 42.9 62.8 61.8^ 0.83 0.85 0.82^ 0.86^
Higher (>3 years) 75 24.8 65.4 61.6^ 0.82 0.85 0.82^ 0.85^
Diagnosis
Pre-diabetes 136 39.5 65.2 - 0.83 0.85 - -
Type 2 diabetes 208 60.5 63.6 59.7 0.84 0.86 0.79 0.83
Only questionnaires with at least 7 items answered were included
* The extreme age group was 45–54 and 75–84 in the American version
^ Education in the American version is slightly different categorised: high school or less, some college and college graduate+
Table 5: Response category measures and fit for 13-items Patient Activation Measure (n = 344)
Response category Observed count % Observed measure Expected measure Infit MNSQ Outfit MNSQ Treshold
Strongly disagree 51 1 -0.30 -0.80 1.26 1.52 NONE
Disagree 368 10 0.18 0.17 1.03 1.03 -2.31
Agree 2185 58 1.59 1.63 0.91 0.88 -0.93
Agree strongly 1153 31 3.70 3.65 0.96 0.96 3.25
Observed measure: the average of the measures that are model led to produce the responses observed in the category
Expected measure: the expected value of the average measure for this sample
Infit: information-weighted fit statistic
Outfit: outlier-sensitive fit statistic
MNSQ: mean-square statistic with expectation 1.0
Treshold: the calibrated measure of the transition from the category below to this category. The bottom category has no prior transition, and so 
that the measurePage 6 of 9
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chronic diseases. If a similar item sequence is found in
future studies in a Danish population, the PAM13 may
need revision. The test items should be reordered to rep-
resent consecutive item difficulty, if the originally pro-
posed model with four stages of activation identified by
Hibbard et al [5] is to be of significance in the Danish ver-
sion. Further, the person reliability did not indicate an
ability to separate four levels at all. This may be due to dif-
ferences between the Danish and the American popula-
tions, but as mentioned, the psychometric results in many
instances replicate the American findings.
The investigation of the scale properties in general showed
that PAM13 may be regarded as a unidimensional scale
performing as a Guttmann sum-scale. This was particu-
larly true for the reliability measures, measures of unidi-
mensionality and aspects of the response categories. We
found e.g. that the scale could distinguish between 2–3
levels as the person reliability was between 0.8–0.9, and
the statistics indicated that each item could be regarded as
part of one dimension (infit and outfit). The high-reliabil-
ity estimates at the person level indicate that the scale is
appropriate on an individual basis to diagnose activation
and individualise plans for future health care as suggested
[5].
However, we noted some possible problems with ceiling
effect, potentially irrelevant items, and important aspects
for responsiveness and separation difficulties at three
points in the scale. Most PAM13 items demonstrated a
ceiling effect and Items 1 to 3 had more than 50% of the
answers in "agree strongly". This percentage suggests that
the response categories do not cover relevant answers for
the study population. Caution must be taken in future
studies if ceiling effects are common in Danish popula-
tions. The high ceiling effect may be a problem if PAM13
is to be used for measuring change over time (e.g. in ran-
domised studies) because of low responsiveness.
The five items with more than 10% answers in "not appli-
cable" indicate that the scale cannot be used for all types
of patients with chronic diseases and a revision of these
items might be necessary.
On three points, there seemed to be no additional infor-
mation when answering the next item in the scale (no sep-
aration). This means that 2–3 items can be omitted from
the scale as a simple sum-scale. Further research will clar-
ify the items to be omitted.
Although we may conclude that the Rasch analysis sup-
ports the PAM13 as a unidimensional sum-scale, some
results do, however, indicate a need for improvement. We
noted that six items had low correlations with the sum of
the rest of the items, which indicates that they may not be
absolutely true to one dimension. In addition, the test for
other dimensions (PCA) revealed a possible additional
factor. However, criteria for deciding whether there are
two or more dimensions and when a deviation becomes a
dimension have yet to be established. To the best of our
knowledge, the rule of thumb is [24] that variance
explained by measures four times greater than the vari-
ance explained by the additional factor and the size of the
components less than three, is good. Our analysis does
therefore not indicate more than one dimension.
When testing for differential item-function, most items
did not have DIF in subgroups. However, items revealing
DIF (item 1, 2, 10 and 13) showed possible explanations
for this. Items 1 and 2 may appeal to educated people,
being responsible and taking action. Gender seemed to
play a role for item 10, which was endorsed by men more
often than women, setting less demanding goals for their
lifestyle changes. Patients aged 65–74 who answered
more convincingly to item 13 may be explained by more
experience of maintaining lifestyle even during stress.
The activation score in the Danish version covered the
range from 33.3–57.5, which is more than the range of
38.6–53.0 for the American data [4]. However, this may
not be enough to be able to detect changes in underlying
behaviour studies, and in particular clinically relevant
changes, which subsequently have to be tested.
Strengths and limitations
The systematic translation approach was a strength in this
study. Translation has no best practice as yet [9,28] and in
particular, the value of back-translation has recently been
questioned [29]. In our study, the backward translation
procedure contributed with new perspectives on the cul-
tural differences in the health care concepts.
We obtained a high response rate with 74% answering
more than half of the items. This may minimise the risk of
selection bias. The sample size of 344 persons was suffi-
cient for this validation study as a minimum of 300
respondents is recommended to replicate structural anal-
yses [19]. The mean square statistics used in the Rasch
analysis are moderately insensitive of sample size for pol-
ytomous data [30].
The fact that PAM13 was delivered as part of a larger ques-
tionnaire at the 12-month follow-up of a health education
intervention study might have affected the actual score
level, but it is unlikely to have changed the scale proper-
ties. The number of missing values may have been higher
that at the baseline questionnaire due the respondents
being fatigued by the questionnaire.Page 7 of 9
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BMC Public Health 2009, 9:209 http://www.biomedcentral.com/1471-2458/9/209The rather heterogeneous group of patients may be
regarded as a weakness in many instances. However, when
assessing scale properties, the use of a population repre-
senting many levels of activation is an advantage. A pop-
ulation screen-detected with dysglycaemia represents
merely one of a range of chronic conditions.
Conclusion
A Danish version of PAM13 measuring the latent variable
of patient activation in chronic care is now available,
although further development is recommended before
use in daily practice. The PAM13 questionnaire was trans-
lated and adapted into Danish in a sample with screen-
detected dysglycaemia showing initial reasonably good
validity and reliability.
The Danish version formed a unidimensional, Guttman-
like scale. The order of the items differed compared with
the American version and therefore the suggested four
activation stages in the American version were not rele-
vant. Our findings show that the Danish PAM13 has
promising psychometric properties indicating that going
on with further validation in other populations with
chronic diseases is expedient. However, special attention
to discrimination and responsiveness is required to be
able to use the score as a screening tool for tailored inter-
ventions. These studies have to be carried out before we
have a much requested fully evidence-based activation
measure for use in Danish chronic care intervention stud-
ies and in daily practice.
Abbreviations
DIF: Differential Item Functioning; MNSQ: Mean Square;
PAM13: Patient Activation Measure 13-items; PCA: Princi-
pal Components Analysis.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
HTM has contributed with the idea and the design and the
acquisition of data. Furthermore, she has performed the
data processing and interpreted the data in cooperation
with a statistician. Finally, she wrote the first draft of the
paper and did the revision. IS participated in the design of
the study and performed the statistical analysis. PV con-
ceived of the study together with HTM, and participated in
its design and coordination and helped to draft the man-
uscript. All authors read and approved the final manu-
script.
Acknowledgements
We thank the participants that filled in the PAM13. We are grateful to 
Judith Hibbard and colleagues for the permission to translate PAM13 into 
Danish. We appreciated the help from Martin Tusler, who shared his expe-
rience and provided information on the development of the original PAM. 
Our work was funded by the Centre for Innovation in Nursing Education, 
Aarhus, the Danish Nurses' Organization, Novo Nordic and the Danish 
Diabetes Association. Thanks to Annelli Sandbaek, Morten Pilegaard, Eva 
Hojmark, Robert Hay and Janet Mikkelsen for participating in the expert 
panel.
References
1. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A:
Improving chronic illness care: translating evidence into
action.  Health Aff (Millwood) 2001, 20(6):64-78.
2. Bodenheimer T, Wagner EH, Grumbach K: Improving Primary
Care for Patients With Chronic Illness.  JAMA 2002,
288(14):1775-9.
3. Hibbard JH, Stockard J, Mahoney ER, Tusler M: Development of
the Patient Activation Measure (PAM): Conceptualizing and
Measuring Activation in Patients and Consumers.  Health Serv-
ices Research 2004, 39(4p1):1005-26.
4. Hibbard JH, Mahoney ER, Stockard J, Tusler M: Development and
Testing of a Short Form of the Patient Activation Measure.
Health Services Research 2005, 40(6p1):1918-30.
5. Hibbard JH, Tusler M: Assessing activation stage and employing
a "next steps" approach to supporting patient self-manage-
ment.  J Ambul Care Manage 2007, 30(1):2-8.
6. Hibbard JH, Mahoney ER, Stock R, Tusler M: Do Increases in
Patient Activation Result in Improved Self-Management
Behaviors?  Health Services Research 2007, 42(4):1443-63.
7. Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J:
Is patient activation associated with outcomes of care for
adults with chronic conditions?  J Ambul Care Manage 2007,
30(1):21-9.
8. World Health organization: Process of translation and adapta-
tion of instruments.  WHO 2007 [http://www.who.int/
substance_abuse/research_tools/translation/].
9. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz
A, et al.: Principles of Good Practice for the Translation and
Cultural Adaptation Process for Patient-Reported Out-
comes (PRO) Measures: report of the ISPOR Task Force for
Translation and Cultural Adaptation.  Value Health 2005,
8(2):94-104.
10. Willis GB: Cognitive Interviewing: A "How To" Guide. Reduc-
ing survey error through research on the cognitive and
design processes in surveys. Short course presented at the
1999 meeting of the American Statistical Association.
Research Triangle Institute.  Research Triangle Institute; 1999. 
11. Maindal TH: Development and Evaluation of "The Ready to
Act" education intervention focusing on Action Compe-
tence in a screen-detected population with dysglycaemia.  In
PhD thesis University of Aarhus, Aarhus; 2009. 
12. Sandbaek A, Griffin SJ, Rutten G, Davies M, Stolk R, Khunti K, et al.:
Stepwise screening for diabetes identifies people with high
but modifiable coronary heart disease risk. The ADDITION
study.  Diabetologia 2008, 51(7):1127-34.
13. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel
BH, Rutten G: The ADDITION study: proposed trial of the
cost-effectiveness of an intensive multifactorial intervention
on morbidity and mortality among people with Type 2 dia-
betes detected by screening.  Int J Obes Relat Metab Disord 2000,
24(Suppl 3):S6-11.
14. Bond TG, Fox CM: Applying the Rasch Model. Fundamental
Measurement in the Human Sciences.  2nd edition. Mahwah,
New Jersey, Lawrence Erlbaum Associates; 2007. 
15. Linacre J: Estimating measures with known polytomous item
difficulties.  Rasch Measurement Transactions 1998, 12(2):638.
16. McHorney CA, Tarlov AR: Individual-patient monitoring in clin-
ical practice: are available health status surveys adequate?
Qual Life Res 1995, 4(4):293-307.
17. Sitzia J: How valid and reliable are patient satisfaction data?
An analysis of 195 studies.  Int J Qual Health Care 1999,
11(4):319-28.
18. McDowell I: Measuring Health – A Guide to Rating Scales and
Questionnaires.  Oxford: Oxford University Press, Inc; 2006. 
19. Clark A, Watson D: Constructing Validity: Basic Issues in
Objective Scale Development.  Psychological Assesment 1995,
7:309-19.Page 8 of 9
(page number not for citation purposes)
BMC Public Health 2009, 9:209 http://www.biomedcentral.com/1471-2458/9/209Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
20. Fayers PM, Machin D: Quality of Life. Assessment, Analysis and
Interpretation.  Chichester: John Wiley & Sons, Ltd; 2007. 
21. Rasch G: Probabilistic models for some intelligence and
attainment tests. Expanded edition (1980) with foreword
and afterword by B.D. Wright ed.  Chicago: (Danish Institute for
Educational Research, Copenhagen); 1960. 
22. Andrich D: A rating formulation for ordered response catego-
ries.  Psychometrika 1978, 43:357-74.
23. Streiner DL, Norman GR: Health Measurement Scales – a prac-
tical guide to their development and use.  2003 [http://
www.oup.com]. Oxford University Press
24. Linacre J: User's guide and program manual to WINSTEPS:
Rasch model computer programs.  Chicago: MESA Press; 2007. 
25. Silverstein BP, Kilgore KM, Fisher WP, Harley JP, Harvey RF: Apply-
ing psychometric criteria to functional assessment in medi-
cal rehabilitation: I. Exploring unidimensionality.  Arch Phys
Med Rehabil 1991, 72(9):631-637.
26. Smith RM: Polytomous Mean-Square Fit Statistics.  Rasch Meas-
urement Transactions 1996, 10(3):516-7.
27. StataCorp: Stata Statistical Software: Release 10.0.  College
Station, TX: StataCorp; 2007. 
28. Acquadro C, Conway K, Hareendran A, Aaronson N: Literature
Review of Methods to Translate Health-Related Quality of
Life Questionnaires for Use in Multinational Clinical Trials.
Value Health 2008, 11(3):509-521.
29. McKenna SP, Doward LC: The translation and cultural adapta-
tion of patient-reported outcome measures.  Value Health
2005, 8(2):89-91.
30. Smith AB, Rush R, Fallowfield LJ, Velikova G, Sharpe M: Rasch fit sta-
tistics and sample size considerations for polytomous data.
BMC Med Res Methodol 2008, 8:33.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/9/209/pre
pubPage 9 of 9
(page number not for citation purposes)
